Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Evolus Community
NasdaqGM:EOLS Community
1
Narratives
written by author
0
Comments
on narratives written by author
18
Fair Values set
on narratives written by author
Create a narrative
Evolus
Popular
Undervalued
Overvalued
Community Investing Ideas
Evolus
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
International Expansion And New Offerings Will Transform Aesthetic Markets
Key Takeaways International expansion and product diversification are expected to drive revenue growth, reduce earnings risk, and strengthen the company's competitive position. Operational scaling, strong consumer loyalty, and recent debt refinancing will support margin improvement and fund further strategic investments.
View narrative
US$23.57
FV
59.6% undervalued
intrinsic discount
30.49%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
EOLS
EOLS
Evolus
Your Fair Value
US$
Current Price
US$9.53
64.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-137m
736m
2015
2018
2021
2024
2025
2027
2030
Revenue US$735.7m
Earnings US$105.8m
Advanced
Set Fair Value